SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A sharp pullback after AEHRs AI-driven rally has traders debating whether the shares are correcting from an excessive valuation or presenting a buying opportunity. Bulls point to AI chip-testing demand and strong guidance, while skeptics question whether enough large new orders will materialize to justify expectations.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package and International Package. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

Amazons launch of Supply Chain Services is raising concern that it could intensify competition for UPS and FedEx across freight, fulfillment, and parcel delivery, pressuring UPS shares. Traders debate whether Amazons scale threatens UPSs market share and margins or whether the selloff is an overreaction given UPSs established network and customer base.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

A bearish short thesis questioning Vevyes revenue ramp, rebate and copay costs, and differentiation is drawing attention as HROW falls; traders also speculate that Opaleye may be selling or unwinding its position, though that remains unconfirmed. The debate reflects broader doubts about execution and upcoming revenue results, countered by investors who remain optimistic about Harrows growth prospects.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is drawing attention ahead of scheduled clinical updates, led by CTX310 Phase 1b data at the American Heart Association meeting and a zugo-cel update at ACR. Traders see the readouts as potential catalysts but remain divided, with many frustrated by the stocks prolonged range-bound trading and recent weakness while others are buying ahead of the data.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as dividend and value stocks outperform amid weakness in technology and semiconductors, with traders describing it as a defensive portfolio holding. Many are adding or continuing to dollar-cost average, while others debate whether the rally can last and note that rising Treasury yields may pressure dividend-focused funds.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluences sharply reduced FY2026 outlook, driven by continuing production delays at its Houston contract-manufacturing facility, has focused attention on its ability to deliver backlog and restore margins. Traders are debating whether strong storage demand and a new operations-focused COO can support a recovery, while many remain bearish over repeated guidance cuts and damaged management credibility.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Traders are speculatingwithout confirmationabout a possible reverse split or share buyback as ALM sells off, with some blaming broader market and energy-price pressures on miners. The debate pits near-term bearishness against longer-term confidence in Almontys tungsten business and Sangdong ramp-up.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing attention over its volatile price and weekly distributions as traders track its exposure to MicroStrategy and Bitcoin. Holders focus on the cash payouts and potential recovery, while critics point to NAV erosion, declining distributions, and the risk of another reverse split.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax is drawing attention around its WiseEye chips reported inclusion in Alibabas Qwen N1 smart glasses and its T2000 controller in E Inks new color-paper technology; traders are also speculating, without confirmation, about a Samsung supplier deal. Optimism about these design wins is tempered by concern over the stocks sharp pullback and weakness across semiconductors amid rate and inflation worries.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies move to new highs is drawing attention amid a broader rotation into defensive healthcare stocks as technology shares weaken. Traders are largely bullish on its relative strength and breakout, though some caution that the stock is overextended; separate speculation about AbbVie as a potential Sellas buyer remains unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Trust Exchange-Traded Fund VIII - FT Vest U.S. Equity Deep Buffer ETF - October

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$48.31
Prev Close	$48.30
Open	$48.31
Dividend Yield	N/A
50-Day Moving Average	$47.84
Beta	N/A
Avg. Volume	7,900.13
PE Ratio	N/A

52-Week High	$48.42
52-Week Low	$42.76
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

DOCT Fundamentals